IRF8 and chronic myelogenous leukemia, BCR-ABL1 positive: The function of Icsbp in controlling the transition of LSK to LSK− cells was also demonstrated in BXH2 mice, in which the function of Icsbp is impaired by a R294C mutation, leading to an eventual development of CML-like disease [21].